In this episode, we sit down with Dr. Cesar Rodriguez of Mount Sinai Hospital in New York, NY to discuss the evolving landscape of myeloma treatment. Groundbreaking innovations are bringing new hope to patients and caregivers. Dr. Rodriguez breaks down the latest advancements in immunotherapy, including CAR T-cell therapy and bispecific antibodies. Hear how researchers and physicians are working to make myeloma into a manageable, long-term disease, while ultimately searching for a cure.

Mentioned on this episode: 

• 
  
• Myeloma
  
  
• Monoclonal Gammopathy of Undetermined Significance (MGUS) and Related Conditions
  
  
• Amyloidosis
  
  
• Revised International Staging System (R-ISS)
  
  
• LLS Clinical Trial Support Center
  
  
• Autologous stem cell transplantation
  
  
• Autologous stem cell transplant animated video
  
  
• CAR T-cell therapy
  
  
• Bispecific antibodies – Immunotherapy fact sheet
  

Additional LLS Support Resources: 

• 
  
• Free Nutrition Consultations
  
  
• Information Specialists 
  
  
• Financial support
  
  
• Free telephone/web patient programs 
  
  
• Free booklets 
  
  
• Young Adult Resources
  
  
• Online chats 
  
  
• Support groups 
  
  
• Caregiver support 
  
  
• Caregiver Workbook
  
  
• Advocacy and Public Policy
  
  
• Survivorship Workbook
  
  
• LLS Community 
  
  
• Mental Health Resources
  

Supported by Genentech, A Member of the Roche Group; and Johnson & Johnson.

The post Hope in Myeloma: The Road to Long-Term Survival first appeared on The Bloodline with LLS.